NanoEcho’s system – intended to meet market requirements – is now being used in an ongoing clinical development study
NanoEcho is developing a system with the aim to offer the healthcare a more precise, simple, and cost-effective rectal cancer diagnosis. The prototype system used in the ongoing investigator-led clinical development studies has now been replaced with a system intended to meet market requirements. The first examination on surgically removed rectal cancer tissue with this system has now been performed.
NanoEcho has been cleared to start a clinical development study at Skåne University Hospital in Malmö. The ethics committee has already approved the study and recruitment of patients is planned to commence during the fall.